
Boehringer Ingelheim is beginning a new push in lung disease across Europe after being approved by regulators in nine countries …

A complaint made by a pharmacist stating that the artwork image for Boehringer Ingelheim’s COPD drug Striverdi is misleading has …
Boehringer Ingelheim is to spend more than €100 million at its Dortmund site in Germany in order to expand the …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

